WASHINGTON—Researchers and policy makers estimated that 300,000 to 400,000 people in the U.S. had multiple sclerosis in 2010, but new data indicates that number grossly undercounted the number of people affected by the neurological disease.
BALTIMORE—A University of Maryland research team has discovered a biomarker that can determine whether a patients has multiple sclerosis or is relapsing, thanks to VA funding.
The prevalence of multiple sclerosis in the United States population appears to be nearly double previous estimates. Among servicemembers, however, the rate of new MS diagnoses has dropped significantly in recent years.
OKLAHOMA CITY — While multiple sclerosis (MS) itself remains incurable, development of more effective treatments over the past 25 years has increased life expectancy for patients with the disease. Today, MS patients have a life expectancy only about seven years less than individuals without the disease, according to the National Multiple Sclerosis Society.